1. Unaudited Financial Results for Quarter Ended June 30, 2026
The Board approved the unaudited standalone financial results for the quarter ended June 30, 2026, along with the Limited Review Report. Key financial figures (in ₹ lakhs) are as follows:
Quarter Ended June 30, 2026 (Unaudited) vs. Comparative Periods:
- Revenue from operations: ₹2,492.56 (vs. ₹448.52 in Q1 FY26; ₹1,676.14 in Q4 FY26)
- Other Income: ₹16.09
- Total Revenue: ₹2,508.65
- Total Expenses: ₹2,360.99
- Purchase of stock-in-trade: ₹2,551.38
- Changes in inventories: (₹516.29)
- Employee benefits expense: ₹66.23
- Finance Costs: ₹23.28
- Depreciation and amortization: ₹35.93
- Other expenses: ₹204.42
- Profit before tax: ₹147.66 (vs. ₹24.06 in Q1 FY26)
- Tax expense: ₹25.00 (Current Tax)
- Profit for the period: ₹122.66 (vs. ₹24.06 in Q1 FY26)
- Earnings Per Share (Basic): ₹0.61 (vs. ₹0.12 in Q1 FY26)
- Earnings Per Share (Diluted): ₹0.57
- Paid-up equity share capital: ₹1,999.85 lakh
- Net Worth: ₹2,902.23 lakh
Notes to Financial Results:
- The financial results were reviewed by the Audit Committee and approved by the Board.
- Prepared in accordance with Indian Accounting Standards (Ind AS).
- The company operates in a single segment: 'Healthcare Pharma Products'.
- During the quarter, the company received ₹487.25 lakh as part consideration for the issue of 1,00,00,000 warrants convertible into equity shares, approved by shareholders under SEBI ICDR Regulations.
2. Director's Report
The Board approved the Director's Report for the financial year ending March 31, 2026.
3. 34th Annual General Meeting
The Board decided to convene the 34th Annual General Meeting (AGM) of the company on Wednesday, September 23, 2026, at 04:00 P.M. through video conferencing.
4. Resignation of Company Secretary and Compliance Officer
The Board accepted the resignation of Ms. Ashita Chittora (Membership No. A50327) from the position of Company Secretary and Compliance Officer, effective from the closure of business hours on August 13, 2026. The reason for resignation was stated as pursuance of a better opportunity. Ms. Chittora confirmed there were no other material reasons for her resignation.
5. Appointment of New Company Secretary and Compliance Officer
Based on the recommendation of the Nomination and Remuneration Committee, the Board approved the appointment of Ms. Ruchi Shah (Membership No. A80942) as the Company Secretary & Compliance Officer of the company, effective August 13, 2026, pursuant to Section 203 of the Companies Act, 2013.
Profile of Ms. Ruchi Shah:
- Qualifications: Bachelor's in Banking and Insurance; Company Secretary (ICSI)
- Experience: Over 6 years in Corporate Laws, Legal, Secretarial, and related matters
- Relationship: Daughter of Mr. Yogesh Shah, Non-Independent Director-Chairperson of the company